Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79317618 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
2021-04-22 | Application Filed |
2021-08-12 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-08-12 | Status: Live/Pending |
2021-08-18 | Transaction Date |
Owner: | ![]() |
Address | 2/2 Aquatic Dr Frenchs Forest NSW 2086 AU |
Legal Entity Type | |
Legal Entity State | AU |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
260121 | Circles that are totally or partially shaded. |
260316 | Ovals touching or intersecting |
260321 | Ovals that are completely or partially shaded |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Medicines in tablet form for the treatment of nutritional and vitamin deficiencies; medicated preparations in the form of powders, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; veterinary preparations in the form of powder, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of veterinary pharmaceuticals; veterinary preparations, namely, dietary and nutritional supplements for veterinary use; medical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals; medicated supplements for foodstuffs for animals; medicated supplements for foodstuffs for human consumption for medical purposes; medicated skin care preparations; medicated preparations for use as supplements for food for medical purposes; powders for skin care for medical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicinal oils containing vitamins and minerals; oils adapted for pharmaceutical purposes, namely, for the increasing the bioavailability and absorption of active ingredients in foodstuffs and medicines; oils for use in medicine, namely, medicated oils containing vitamins and minerals; dietary supplements; pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic foods adapted for medical purposes; dietetic substances adapted for medical use; dietetic substances for veterinary use; dietary supplements for animals; nutritional meal replacements adapted for medical use; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients; nutritional supplements; medicinal healthcare products, namely, dietary supplements with medicinal properties that increase the bioavailability and absorption of active ingredients in foodstuffs and medicines; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines; biotechnological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; chemical products for medical use, namely, chemical reagents for medical purposes; dietary supplements with a cosmetic effect; medicated skin creams for personal care; medicated preparations for the regeneration of the skin; medicated preparations for the treatment of the skin; medicated preparations for use in the bath; medicated creams for the face |
DM0000 | The mark consists of the stylized wording "CPO" to the right of a stylized concentric oval and circle design. |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-08-12 | 1 REPR M: |
LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2021-08-16 | 2 LIMI I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-18 | 3 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-08-24 | 4 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2021-12-17 | 5 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2021-12-21 | 6 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-12-22 | 7 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2022-01-13 | 8 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-01-13 | 9 RFCS P: |
REFUSAL PROCESSED BY IB | 2022-01-30 | 10 RFNT P: |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-07-08 | 11 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-07-08 | 12 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-07-08 | 13 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-07-08 | 14 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-07-08 | 15 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-07-08 | 16 CHAN I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-07-13 | 17 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-07-13 | 18 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-07-14 | 19 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2022-07-28 | 20 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2022-07-28 | 21 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-07-28 | 22 GNFN O:Outgoing Correspondence |
NEW REPRESENTATIVE AT IB RECEIVED | 2022-09-17 | 23 NREP P: |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2023-01-18 | 24 OPNR P: |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-01-18 | 25 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-01-18 | 26 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-01-18 | 27 TEME I:Incoming Correspondence |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-01-18 | 28 OPNS P: |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-01-26 | 29 CNSA O:Outgoing Correspondence |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2023-02-06 | 30 OPNX P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-02-08 | 31 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-02-08 | 32 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-02-08 | 33 OPNS P: |
NOTIFICATION PROCESSED BY IB | 2023-02-27 | 34 GPNX P: |
PUBLISHED FOR OPPOSITION | 2023-02-28 | 35 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-02-28 | 36 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2023-05-16 | 37 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-05-16 | 38 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-08-16 | 39 FICR P: |
FINAL DISPOSITION PROCESSED | 2023-08-17 | 40 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2023-08-17 | 41 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-09-12 | 42 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.